WELS.DE vs. LYMS.DE

Last updated Jun 5, 2026

WELS.DE (Amundi S&P Global Health Care ESG UCITS ETF EUR Acc) and LYMS.DE (Amundi Nasdaq-100 II UCITS ETF Acc) are both exchange-traded funds - WELS.DE is a Health & Biotech Equities fund tracking the S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care, while LYMS.DE is a Nasdaq-100 fund tracking the Nasdaq 100®. Both are passively managed. Over the past 3 years, WELS.DE returned 2.22%/yr vs 24.71%/yr for LYMS.DE. At a 0.29 correlation, their price movements are largely independent. WELS.DE charges 0.18%/yr vs 0.22%/yr for LYMS.DE.

Performance

WELS.DE vs. LYMS.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Amundi S&P Global Health Care ESG UCITS ETF EUR Acc (WELS.DE) and Amundi Nasdaq-100 II UCITS ETF Acc (LYMS.DE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, WELS.DE achieves a -3.35% return, which is significantly lower than LYMS.DE's 20.63% return.

WELS.DE

• 1D: 2.97%
• 1M: 4.14%
• YTD: -3.35%
• 6M: -2.82%
• 1Y: 6.93%
• 3Y*: 2.22%
• 5Y*: —
• 10Y*: —

LYMS.DE

• 1D: -0.86%
• 1M: 7.96%
• YTD: 20.63%
• 6M: 18.72%
• 1Y: 37.20%
• 3Y*: 24.71%
• 5Y*: 18.88%
• 10Y*: 21.41%

*Multi-year figures are annualized to reflect compound growth (CAGR)

WELS.DE vs. LYMS.DE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
WELS.DE Amundi S&P Global Health Care ESG UCITS ETF EUR Acc	-3.35%	1.05%	7.20%	2.33%	4.02%
LYMS.DE Amundi Nasdaq-100 II UCITS ETF Acc	20.63%	7.15%	33.72%	51.52%	-9.07%

Correlation

The correlation between WELS.DE and LYMS.DE is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.28
Correlation (All Time) Calculated using the full available price history since Oct 12, 2022	0.29

The correlation between WELS.DE and LYMS.DE shifts across timeframes, from 0.14 (1 year) to 0.29 (all time), reflecting how their relationship changes across market environments.

Return for Risk

WELS.DE vs. LYMS.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WELS.DE

WELS.DE Risk / Return Rank: 16
WELS.DE Sharpe Ratio Rank: 17
WELS.DE Sortino Ratio Rank: 17
WELS.DE Omega Ratio Rank: 16
WELS.DE Calmar Ratio Rank: 16
WELS.DE Martin Ratio Rank: 15

LYMS.DE

LYMS.DE Risk / Return Rank: 71
LYMS.DE Sharpe Ratio Rank: 75
LYMS.DE Sortino Ratio Rank: 71
LYMS.DE Omega Ratio Rank: 72
LYMS.DE Calmar Ratio Rank: 75
LYMS.DE Martin Ratio Rank: 63

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WELS.DE vs. LYMS.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amundi S&P Global Health Care ESG UCITS ETF EUR Acc (WELS.DE) and Amundi Nasdaq-100 II UCITS ETF Acc (LYMS.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	WELS.DE	LYMS.DE	Difference
Sharpe ratio: Return per unit of total volatility	0.47	2.40	-1.93
Sortino ratio: Return per unit of downside risk	0.82	3.19	-2.36
Omega ratio: Gain probability vs. loss probability	1.09	1.42	-0.33
Calmar ratio: Return relative to maximum drawdown	0.56	3.77	-3.21
Martin ratio: Return relative to average drawdown	1.30	11.23	-9.94
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

WELS.DE vs. LYMS.DE - Sharpe Ratio Comparison

The current WELS.DE Sharpe Ratio is 0.47, which is lower than the LYMS.DE Sharpe Ratio of 2.40. The chart below compares the historical Sharpe Ratios of WELS.DE and LYMS.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	WELS.DE	LYMS.DE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.47	2.40	-1.93
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.94	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	1.08	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.22	0.77	-0.55

Drawdowns

WELS.DE vs. LYMS.DE - Drawdown Comparison

The maximum WELS.DE drawdown since its inception was -23.13%, smaller than the maximum LYMS.DE drawdown of -50.00%. Use the drawdown chart below to compare losses from any high point for WELS.DE and LYMS.DE.

Drawdown Indicators

	WELS.DE	LYMS.DE	Difference
Max Drawdown Largest peak-to-trough decline	-23.13%	-50.00%	+26.87%
Max Drawdown (1Y) Largest decline over 1 year	-12.35%	-10.02%	-2.33%
Max Drawdown (3Y) Largest decline over 3 years	-23.13%	-26.74%	+3.61%
Max Drawdown (5Y) Largest decline over 5 years	—	-31.12%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-31.12%	—
Current Drawdown Current decline from peak	-12.08%	-0.86%	-11.22%
Average Drawdown Average peak-to-trough decline	-7.30%	-8.78%	+1.48%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.34%	3.37%	+1.97%

Volatility

WELS.DE vs. LYMS.DE - Volatility Comparison

Amundi S&P Global Health Care ESG UCITS ETF EUR Acc (WELS.DE) has a higher volatility of 5.27% compared to Amundi Nasdaq-100 II UCITS ETF Acc (LYMS.DE) at 4.37%. This indicates that WELS.DE's price experiences larger fluctuations and is considered to be riskier than LYMS.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	WELS.DE	LYMS.DE	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.27%	4.37%	+0.90%
Volatility (6M) Calculated over the trailing 6-month period	10.22%	10.99%	-0.77%
Volatility (1Y) Calculated over the trailing 1-year period	14.60%	15.73%	-1.13%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	13.59%	19.91%	-6.32%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	13.59%	19.68%	-6.09%

WELS.DE vs. LYMS.DE - Expense Ratio Comparison

WELS.DE has a 0.18% expense ratio, which is lower than LYMS.DE's 0.22% expense ratio. Despite the difference, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.

Dividends

WELS.DE vs. LYMS.DE - Dividend Comparison

Neither WELS.DE nor LYMS.DE has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
LYMS.DE Amundi Nasdaq-100 II UCITS ETF Acc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.65%	0.69%	0.76%	1.09%	1.18%
WELS.DE Amundi S&P Global Health Care ESG UCITS ETF EUR Acc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both WELS.DE and LYMS.DE in my portfolio?

WELS.DE and LYMS.DE have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, WELS.DE or LYMS.DE?

On fees, WELS.DE is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, WELS.DE or LYMS.DE?

WELS.DE is cheaper with a 0.18% expense ratio, compared with 0.22% for LYMS.DE.

What is the main difference between WELS.DE and LYMS.DE?

WELS.DE is categorized as Health & Biotech Equities, while LYMS.DE is Nasdaq-100. WELS.DE tracks S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care, while LYMS.DE tracks Nasdaq 100®. Their fees differ too: 0.18% for WELS.DE and 0.22% for LYMS.DE.